BioLineRX

BLRX

Börsenwert 9,7 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Senvest Management New York	2,84 Mio. $	–	–	–
2	2 OrbiMed New York	831.000 $	–	–	–
3	3 Alyeska Investment Group Chicago, Illinois	490.000 $	+11.750 $	+21	+2 %
4	4 Morgan Stanley New York	387.000 $	+48.117 $	+86	+12 %
5	5 Millennium Management New York	340.000 $	-69.938 $	-125	-15 %
6	OM 6 Opaleye Management Boston, Massachusetts	223.000 $	–	–	–
7	7 Deutsche Bank Frankfurt Am Main Ge, Germany	194.000 $	–	–	–
8	8 Menta Capital San Francisco, California	79.000 $	-560 $	-1	-0,6 %
9	BCA 9 Benchmark Capital Advisors New York	35.000 $	-2.798 $	-5	-6 %
10	10 Ladenburg Thalmann Financial Services Miami, Florida	32.000 $	–	–	–
11	11 Next Financial Group Houston, Texas	31.000 $	–	–	–
12	12 UBS Group Zurich, Switzerland	29.000 $	+31.892 $	+57	+1.900 %
13	13 Virtu KCG Holdings New York	24.000 $	-99.032 $	-177	-78 %
14	14 Cutter & Co Brokerage Ballwin, Missouri	20.000 $	+23.499 $	+42	Neu
15	ARTA 15 A.R.T. Advisors New York	20.000 $	+24.059 $	+43	Neu
16	16 Commonwealth Equity Services Waltham, Massachusetts	18.000 $	–	–	–
17	17 Two Sigma Securities New York	14.000 $	-2.238 $	-4	-12 %
18	18 Bank of New York Mellon New York	14.000 $	–	–	–
19	19 Bank of America Charlotte, North Carolina	13.000 $	–	–	–
20	20 Creative Planning Overland Park, Kansas	12.000 $	–	–	–
21	21 Royal Bank of Canada Toronto, Ontario, Canada	4.000 $	–	–	–
22	22 Krilogy Financial St. Louis, Missouri	1.000 $	–	–	–
23	23 Wealthcare Capital Management Richmond, Virginia	1.000 $	–	–	–
24	24 Wells Fargo San Francisco, California	1.000 $	–	–	–
25	25 Susquehanna International Group Bala Cynwyd, Pennsylvania	–	-40.000 $	-65	Geschlossen

BioLineRX BLRX Börsenwert 9,7 Mio. $

BioLineRX

BLRX

Börsenwert 9,7 Mio. $